Ibires I Nexpule Benefits & Uses
Ibires I Nexpule is used to treat the following -
Other Benefits
Ibires I Nexpule Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Ibires I Nexpule Side Effects
Based on research, the following side effects have been observed when Ibires I Nexpule is used -
Severe
- Swelling
- Difficulty breathing
- Irregular heartbeat
Moderate
- Blurred vision
- Palpitations (fluttering in chest)
- Respiratory Tract Inflammation
Mild
- Headache
- Dry Mouth
- Nausea or vomiting
- Dizziness (Read More - Home Remedies for Dizziness: Quick Tips for Instant Relief)
- Cough
- Throat Irritation
- Skin Rash (Read More - DIY Skin Rash Relief: Simple Home Remedies That Work)
- Musculoskeletal Pain (Bone, Muscle or Joint)
- Anxiety (Read More - Home Remedies for Anxiety)
Ibires I Nexpule Related Warnings
-
Is the use of Ibires I Nexpule safe for pregnant women?
Ibires I shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
-
Is the use of Ibires I Nexpule safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Ibires I. It should only be taken after medical advice.
-
What is the effect of Ibires I Nexpule on the Kidneys?
Very few cases of side effects of Ibires I on kidney have been reported.
-
What is the effect of Ibires I Nexpule on the Liver?
Ibires I can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
-
What is the effect of Ibires I Nexpule on the Heart?
You may experience side effects on your heart after taking Ibires I. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Severe Interaction of Ibires I Nexpule with Other Drugs
Ibires I Nexpule should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
Ibires I Nexpule Contraindications
If you are suffering from any of the following diseases, you should not take Ibires I Nexpule unless your doctor advises you to do so -
- Glaucoma
- Gastritis
- Drug Allergy
- Liver Disease
- Tachycardia
- Urinary Retention
- Diabetes
- Potassium Deficiency
- Kidney Disease
- Heart Disease
- Asthma
Frequently asked Questions about Ibires I Nexpule
-
Is this Ibires I Nexpule habit forming or addictive?
Ibires I Nexpule is not addictive in nature.
Ibires I Nexpule Interactions with Food and Alcohol
-
Interaction between Food and Ibires I Nexpule
Information is not available on the interaction of any foods with Ibires I Nexpule, due to a lack of research on this.
-
Interaction between Alcohol and Ibires I Nexpule
It is difficult to say anything about the effect of Ibires I Nexpule and alcohol. No research has been done on this yet.
See all substitutes for Ibires I
- Combimist L CFC Free Inhaler - ₹191
- Ventipra MDI Inhaler - ₹182
- Combimist 100 Inhaler - ₹71
- Ibires I Nexpule - ₹36
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 705
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 116
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Atrovent® HFA (ipratropium bromide HFA)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ipravent® (ipratropium bromide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Proventil® HFA (albuterol sulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 118-120
